Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomes.

Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/463

Full metadata record

DC Field	Value	Language
dc.contributor.author	Martin, Jennifer H	-
dc.contributor.author	Phillips, Elizabeth	-
dc.contributor.author	Thomas, David	-
dc.contributor.author	Somogyi, Andrew A	-
dc.date.accessioned	2018-04-08T01:04:34Z	-
dc.date.available	2018-04-08T01:04:34Z	-
dc.date.issued	2015-11	-
dc.identifier.citation	British journal of clinical pharmacology 2015-11; 80(5): 929-31	-
dc.identifier.uri	http://hdl.handle.net/11055/463	-
dc.language.iso	eng	-
dc.subject.mesh	Neoplasms	-
dc.subject.mesh	Precision Medicine	-
dc.title	Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomes.	-
dc.type	Editorial	-
dc.identifier.journaltitle	British journal of clinical pharmacology	-
dc.identifier.doi	10.1111/bcp.12690	-
dc.description.pubmeduri	https://www.ncbi.nlm.nih.gov/pubmed/26507561	-
dc.identifier.pubmedid	26507561	-
item.languageiso639-1	en	-
item.fulltext	No Fulltext	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.grantfulltext	none	-
item.openairetype	Editorial	-
item.cerifentitytype	Publications	-
Appears in Collections:	Scholarly and Clinical

Check